Author name: Common Stock Warrants

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and … – Marketwired (press release)

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and …Marketwired (press release)Where the Consolidation results in a fractional Common Share, the number of post-Consolidation Common Shares will be rounded down to a lower unit where the fraction obtained is less than 0.5 and rounded up to the higher unit where the fraction obtained … …read more

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and … – Marketwired (press release) Read More »

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and … – Wall Street Journal

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and …Wall Street JournalWhere the Consolidation results in a fractional Common Share, the number of post-Consolidation Common Shares will be rounded down to a lower unit where the fraction obtained is less than 0.5 and rounded up to the higher unit where the fraction obtained … …read more

Northcore-Share Consolidation 20:1, Private Placement Price Reservation and … – Wall Street Journal Read More »

Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results … – Seeking Alpha (registration)

Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results …Seeking Alpha (registration)… the March 2014, $59 million public offering of common stock proceeds from the July 2013, $5.4 million public offering of Series C Preferred Stock and Warrants, and the exercise of certain outstanding warrants throughout the year for proceeds of $7 …Oxygen Biotherapeutics Announces Fiscal

Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results … – Seeking Alpha (registration) Read More »

ContraFect Prices IPO At $6.00 Per Unit – RTT News

ContraFect Prices IPO At $6.00 Per UnitRTT NewsOn or prior to September 12, 2014, the units will separate into three classes of securities: common stock, Class A Warrants and Class B Warrants, and such component securities will begin trading as separate securities. The common stock is expected to …IPO Report: ContraFect (CFRXU)Equities.com all 5 news

ContraFect Prices IPO At $6.00 Per Unit – RTT News Read More »

ContraFect Prices IPO At $6.00 Per Unit – RTT News

ContraFect Prices IPO At $6.00 Per UnitRTT NewsOn or prior to September 12, 2014, the units will separate into three classes of securities: common stock, Class A Warrants and Class B Warrants, and such component securities will begin trading as separate securities. The common stock is expected to …IPO Report: ContraFect (CFRXU)Equities.com all 5 news

ContraFect Prices IPO At $6.00 Per Unit – RTT News Read More »

IPO Preview: ContraFect (CFRX) – Seeking Alpha (registration)

IPO Preview: ContraFect (CFRX)Seeking Alpha (registration)Biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. High price to book, 5.6. High cash burn …ContraFect Announces Pricing of Its Initial Public OfferingMarketwired (press release)IPO Report: ContraFect (CFRXU)Equities.com all 6 news articles …read more

IPO Preview: ContraFect (CFRX) – Seeking Alpha (registration) Read More »

White Mountains Reports Adjusted Book Value Per Share Of $667, Up 1.7% For … – CNNMoney

White Mountains Reports Adjusted Book Value Per Share Of $667, Up 1.7% For …CNNMoneyHAMILTON, Bermuda, July 29, 2014 /PRNewswire/ — White Mountains Insurance Group, Ltd. (NYSE: WTM) reported an adjusted book value per share of $667 at June 30, 2014, up 1.7% for the second quarter of 2014 and up 4.0% for the first six

White Mountains Reports Adjusted Book Value Per Share Of $667, Up 1.7% For … – CNNMoney Read More »

Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results – Wall Street Journal

Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial ResultsWall Street Journal… year, including proceeds from the March 2014 $59.8 million public offering of Common Stock; proceeds from the July 2013 $5.4 million public offering of Series C Preferred Stock and Warrants, and the exercise of certain outstanding warrants of $7.0 … and more …read more

Oxygen Biotherapeutics Announces Fiscal Year 2014 Financial Results – Wall Street Journal Read More »

ContraFect Announces Pricing of Its Initial Public Offering – EIN News (press release)

ContraFect Announces Pricing of Its Initial Public OfferingEIN News (press release)On or prior to September 12, 2014, the units will separate into three classes of securities: common stock, Class A Warrants and Class B Warrants, and such component securities will begin trading as separate securities. The common stock is expected to …IPO Report: ContraFect (CFRXU)Equities.com

ContraFect Announces Pricing of Its Initial Public Offering – EIN News (press release) Read More »

Scroll to Top